STRIDE investigator Marc Bonaca, MD, MPH, University of Colorado School of Medicine, highlights how the data could provide insight into peripheral artery disease and type 2 diabetes treatment options.
A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million ...
The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback